What's new? Log in Free sign up

Filing search / Kineta, Inc. / "Package"

Search information

Kineta, Inc.

Companies

"Package"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

41 results

Newest first Best match first

KANT Kineta, Inc.

Definitive proxy

(Effective April 1, 2023) Initial Grant Annual Grant This program is intended to provide a total compensation package that enables us to attract and retain

26 Apr 24

4:00pm

KANT Kineta, Inc.

Definitive proxy

Options (Effective April 1, 2023) Initial Grant Annual Grant This program is intended to provide a total compensation package that enables us

28 Apr 23

5:09pm

KANT Kineta, Inc.

of the agreement, April 2018, and would expire (i) three months after the Company delivered to Genentech the IND filing package for a product … data package for such product. If Genentech exercised the option, Genentech would be responsible for further development and commercialization

31 Mar 23

4:05pm

KANT Kineta, Inc.

Kineta Completes Reverse Merger with Yumanity Therapeutics

, and expires (i) three months after the Company delivers to Genentech the IND filing package for a product incorporating the first molecule; or (ii … ) if an additional extension payment is provided, four months after the Company delivers to Genentech the Phase I data package for such product. If Genentech

KANT Kineta, Inc.

Quarterly report

, 2021, Merck notified the Company that Merck has accepted the first data package for one program from their research collaboration with the Company … research and development activities. On December 17, 2021, Merck notified us that the first data package that we submitted for one program has met

14 Nov 22

8:44am

Registration of securities issued in business combination transactions (amended)

24 Oct 22

9:14am

sg0w5kp ijuckmazg

Registration of securities issued in business combination transactions (amended)

3 Oct 22

4:54pm

Registration of securities issued in business combination transactions (amended)

3 Oct 22

4:54pm

y1dvwqarjc0oxi8l 35

Registration of securities issued in business combination transactions (amended)

3 Oct 22

4:54pm

qz3df0f24ag8f04xbhk

Registration of securities issued in business combination transactions (amended)

3 Oct 22

4:54pm

Registration of securities issued in business combination transactions (amended)

3 Oct 22

4:54pm

Quarterly report

4 Aug 22

5:12pm

Quarterly report

12 May 22

4:59pm

Definitive proxy

25 Apr 22

4:01pm

24 Mar 22

4:31pm

fr19lzw6e5o9afxwrn1

Yumanity Therapeutics Appoints Michael D. Wyzga as Chief Financial Officer and Announces Inducement Grants

Quarterly report

12 Aug 21

4:23pm

oyrri9fyi3 4pctuz6

Quarterly report

12 Aug 21

4:23pm

Definitive proxy

22 Apr 21

4:48pm

Prev
1
2
3
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.